Fortrea Holdings Inc.FTREEarnings & Financial Report
Nasdaq · Health Care · Services-Medical Laboratories
Fortrea Holdings Inc. is an American contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries.
Revenue
$697.0M
Gross Profit
N/A
Operating Profit
$-55.6M
Net Profit
$-61.2M
Gross Margin
N/A
Operating Margin
-8.0%
Net Margin
-8.8%
YoY Growth
N/A
EPS
$-0.68
Fortrea Holdings Inc. Q4 FY2024 Financial Summary
Fortrea Holdings Inc. reported revenue of $697.0M for Q4 FY2024, with a net profit of $-61.2M (-8.8% margin).
Key Financial Metrics
| Total Revenue | $697.0M |
|---|---|
| Net Profit | $-61.2M |
| Gross Margin | N/A |
| Operating Margin | -8.0% |
| Report Period | Q4 FY2024 |
Fortrea Holdings Inc. Annual Revenue by Year
Fortrea Holdings Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.7B).
| Year | Annual Revenue |
|---|---|
| 2025 | $2.7B |
| 2024 | $2.7B |
Fortrea Holdings Inc. Quarterly Revenue & Net Profit History
Fortrea Holdings Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $660.5M | -5.2% | $-32.5M | -4.9% |
| Q3 FY2025 | $701.3M | +3.9% | $-15.9M | -2.3% |
| Q2 FY2025 | $710.3M | +7.2% | $-374.9M | -52.8% |
| Q1 FY2025 | $651.3M | -1.6% | $-562.9M | -86.4% |
| Q4 FY2024 | $697.0M | — | $-61.2M | -8.8% |
| Q3 FY2024 | $674.9M | -5.4% | $-27.9M | -4.1% |
| Q2 FY2024 | $662.4M | -8.6% | $-138.4M | -20.9% |
| Q1 FY2024 | $662.1M | — | $-101.0M | -15.3% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $662.1M | $662.4M | $674.9M | $697.0M | $651.3M | $710.3M | $701.3M | $660.5M |
| YoY Growth | N/A | -8.6% | -5.4% | N/A | -1.6% | 7.2% | 3.9% | -5.2% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $4.24B | $3.57B | $3.66B | $3.58B | $3.12B | $2.84B | $2.74B | $2.72B |
| Liabilities | $2.65B | $2.10B | $2.15B | $2.22B | $2.26B | $2.25B | $2.16B | $2.15B |
| Equity | $1.59B | $1.46B | $1.51B | $1.36B | $858.8M | $589.2M | $580.8M | $563.5M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-25.6M | $273.7M | $-2.4M | $17.1M | $-124.2M | $21.8M | $86.8M | $129.1M |